Intranasal apomorphine. Nastech Pharmaceutical.

IDrugs : the investigational drugs journal

Volumn 7, Issue 5, 2004, Pages 483-488

  Kendirci, Muammer ^a   Hellstrom, Wayne J G ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ANIMAL; DRUG CONTRAINDICATION; FEMALE; HUMAN; IMPOTENCE; INTRANASAL DRUG ADMINISTRATION; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PSYCHOSEXUAL DISORDER; REVIEW; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, INTRANASAL; ANIMALS; APOMORPHINE; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DOPAMINE AGONISTS; FEMALE; HUMANS; IMPOTENCE; MALE; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 3142726570     PISSN: 13697056     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)